Back to VANGUARD GROUP INC VANGUARD GROUP INC

ANIPANIP
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in ANI PHARMACEUTICALS INC

As of its last 13F, for Q4 2025, Vanguard Group held 1,305,068 shares of ANIP (Ani Pharmaceuticals), worth $103M. It increased the position by 27,598 shares (+2.2%) from Q3 2025. Vanguard Group held ANIP from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$103M

Current Shares

1.3M

Total Value Change

+$22.6M

Total Shares Change

-43,043

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
1.3M
+2.2%
$103M0.0%$78.94
31
2025-Q3
Increased
1.3M
+0.0%
$117M0.0%$91.60
30
2025-Q2
Increased
1.3M
+8.1%
$83.3M0.0%$65.25
32
2025-Q1
Decreased
1.2M
-10.1%
$79.1M0.0%$66.95
0
2024-Q4
Decreased
1.3M
-2.5%
$72.7M0.0%$55.28
0
2024-Q3
First report
1.3M
-
$80.4M0.0%$59.66
0

Other major holders of ANIP: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used